Surface Oncology, Inc. (SURF) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE, MA 02139 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 124,823 | 154,149 | 175,141 | 105,161 | 158,835 | |||
| Cash and cash equivalent | 50,910 | 56,045 | 175,141 | 46,755 | 82,912 | |||
| Short-term investments | 73,913 | 98,104 | 58,406 | 75,923 | ||||
| Receivables | 197 | 765 | 2,571 | 336 | 323 | |||
| Prepaid expense | 4,120 | 2,432 | 2,797 | 2,429 | 4,520 | |||
| Other undisclosed current assets | 923 | |||||||
| Total current assets: | 129,140 | 157,346 | 180,509 | 107,926 | 164,601 | |||
| Noncurrent Assets | ||||||||
| Operating lease, right-of-use asset | 24,307 | 25,870 | 27,911 | 14,858 | ✕ | |||
| Property, plant and equipment | 4,866 | 5,651 | 6,664 | 7,286 | 8,226 | |||
| Restricted cash and investments | 1,595 | 1,595 | 1,595 | 1,595 | 1,198 | |||
| Other noncurrent assets | 2 | 385 | 459 | 28 | 40 | |||
| Total noncurrent assets: | 30,770 | 33,501 | 36,629 | 23,767 | 9,464 | |||
| TOTAL ASSETS: | 159,910 | 190,847 | 217,138 | 131,693 | 174,065 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 6,105 | 6,085 | 7,057 | 7,174 | 6,664 | |||
| Employee-related liabilities | ✕ | ✕ | 4,180 | 5,056 | 3,380 | 2,618 | ||
| Accounts payable | 256 | 1,550 | 1,674 | 3,384 | 3,412 | |||
| Accrued liabilities | 5,849 | 355 | 327 | 410 | 634 | |||
| Deferred revenue | 4,916 | ✕ | ||||||
| Debt | 5,529 | 2,962 | ||||||
| Deferred rent credit | 352 | |||||||
| Restructuring reserve | ||||||||
| Other liabilities | 2,146 | 3,238 | 1,048 | 754 | 540 | |||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 14,610 | ||
| Other undisclosed current liabilities | 8,009 | 10,700 | 4,017 | 3,468 | 5,011 | |||
| Total current liabilities: | 16,260 | 20,023 | 17,651 | 19,274 | 27,177 | |||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 25,585 | 51,924 | 43,740 | 22,077 | ||||
| Long-term debt, excluding current maturities | 25,585 | 25,015 | 14,759 | 5,109 | ||||
| Liabilities, other than long-term debt | 24,662 | 33,676 | 44,026 | |||||
| Deferred revenue | 33,676 | ✕ | ||||||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 39,342 | ||
| Deferred rent credit | 4,684 | |||||||
| Operating lease, liability | 24,662 | 26,909 | 28,981 | 16,968 | ✕ | |||
| Other undisclosed noncurrent liabilities | (26,909) | |||||||
| Total noncurrent liabilities: | 50,247 | 51,924 | 43,740 | 55,753 | 44,026 | |||
| Total liabilities: | 66,507 | 71,947 | 61,391 | 75,027 | 71,203 | |||
| Equity | ||||||||
| Equity, attributable to parent | 93,403 | 118,900 | 155,747 | 56,666 | 102,862 | |||
| Common stock | 6 | 5 | 4 | 3 | 3 | |||
| Additional paid in capital | 298,741 | 259,859 | 218,001 | 178,155 | 169,784 | |||
| Accumulated other comprehensive income (loss) | (1,015) | (221) | 103 | (119) | ||||
| Accumulated deficit | (204,329) | (140,743) | (62,258) | (121,595) | (66,806) | |||
| Total equity: | 93,403 | 118,900 | 155,747 | 56,666 | 102,862 | |||
| TOTAL LIABILITIES AND EQUITY: | 159,910 | 190,847 | 217,138 | 131,693 | 174,065 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 30,000 | 2,687 | 126,162 | 15,360 | 59,417 | ||
| Sublease income | 3,335 | 3,371 | ✕ | ||||
| Gross profit: | 30,000 | 2,687 | 126,162 | 15,360 | 59,417 | ||
| Operating expenses | (91,869) | (78,700) | (64,576) | (72,726) | (68,568) | ||
| Operating income (loss): | (61,869) | (76,013) | 61,586 | (57,366) | (9,151) | ||
| Nonoperating income (expense) | 1,286 | (733) | 47 | 764 | 377 | ||
| Investment income, nonoperating | (143) | (807) | 47 | 764 | 377 | ||
| Other nonoperating income | 1,429 | 74 | |||||
| Interest and debt expense | (3,146) | (2,546) | |||||
| Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | (2,287) | 1,813 | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (63,729) | (79,292) | 59,346 | (54,789) | (8,774) | ||
| Other undisclosed income from continuing operations before income taxes | 143 | 807 | |||||
| Income (loss) from continuing operations: | (63,586) | (78,485) | 59,346 | (54,789) | (8,774) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | (78,485) | 59,346 | (54,789) | (8,774) | ||
| Other undisclosed net income (loss) | (9) | 2,177 | |||||
| Net income (loss) attributable to parent: | (63,586) | (78,485) | 59,337 | (54,789) | (6,597) | ||
| Preferred stock dividends and other adjustments | (11) | ||||||
| Net income (loss) available to common stockholders, basic: | (63,586) | (78,485) | 59,337 | (54,789) | (6,608) | ||
| Interest on convertible debt | 395 | ||||||
| Net income (loss) available to common stockholders, diluted: | (63,586) | (78,485) | 59,732 | (54,789) | (6,608) | ||
Comprehensive Income ($ in thousands)
| 6/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | (63,586) | (78,485) | 59,337 | (54,789) | (6,597) | ||
| Comprehensive income (loss): | (63,586) | (78,485) | 59,337 | (54,789) | (6,597) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (794) | (221) | (103) | 222 | 127 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (64,380) | (78,706) | 59,234 | (54,567) | (6,470) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.